Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Genetics Investing
Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China Pharmaceutical Investing
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies Genetics Investing
Trillium Therapeutics’ TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma Pharmaceutical Investing
Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne Genetics Investing